Cancer Survivor to Raise $10 Million for Groundbreaking Research

ATLANTA - Jan. 28, 2010 - Cancer survivor and Atlanta businessman Jeff Wigbels officially launched The Wigbels/Herbst Cancer Research Fund (WHCRF) today as the organization’s Board of Advisors prepares for its kick-off meeting Saturday, Jan. 30th. The Fund’s first order of business is to raise $10 million within the next five years for The University of Texas M. D. Anderson Cancer Center (MDACC) and the groundbreaking research taking place at the center’s Institute for Personalized Cancer Therapy. 100% of all proceeds will go directly to fund this critical research.

Wigbels, an accomplished endurance athlete, was diagnosed with Stage IV non-smokers lung cancer on Oct. 11, 2006, one day before the birth of his second child. Rather than accept the recommended “standard of care,” he decided to go to MDACC based on their world-class reputation and innovative research efforts.  There, as a patient in BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination), a program designed to match existing cancer drugs to the molecular aspects of an individual patient’s tumor, Wigbels embarked on the road to recovery.

Wigbels began treatment in December 2006 under the care of Roy S. Herbst, M.D., Ph.D., and BATTLE co-principal investigator. By August 2008, the tumor in his lung had shrunk to half of its original size and the rest of his body was cancer-free.

“This cutting-edge research must continue,” said Wigbels. “It is revolutionizing cancer care and will ultimately raise the standard of care of all oncologists.  I’m so grateful for the gift of life Dr. Herbst and his team have given me, and I am committed to supporting Anderson’s Institute for Personalized Cancer Therapy for many years to come.”

To drive its fundraising efforts, WHCRF is also launching today a consumer website at, where those interested in supporting the fund may go to donate and learn more.

About the Wigbels/Herbst Cancer Research Fund: The mission of WHCRF is to raise funds to support groundbreaking research and make individualized, targeted therapy available to more people battling cancer. 100% of all proceeds go directly to fund research.  Please visit us at 

Donate now to support targeted-therapy cancer research and treatment.

Survivor Wine - Prepare to toast to your health.

Researching and advancing molecular-level cancer therapy for promising results.

LUNGevity YouTube LUNGevity Facebook LUNGevity Twitter